ADDITIONAL INFORMATION

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Cover of Glycerol Phenylbutyrate (Ravicti)

Glycerol Phenylbutyrate (Ravicti) [Internet].

Show details

Contents

< Prev Next >

APPENDIX 2ADDITIONAL INFORMATION

Table 8Submission Quality

	Yes/Good	Somewhat/Average	No/Poor
Are the methods and analysis clear and transparent?	X
Comments	None
Was the material included (content) sufficient?	X
Comments	None
Was the submission well organized and was information easy to locate?	X
Comments	None

Table 9Authors’ Information

Authors of the Pharmacoeconomic Evaluation Submitted to CADTH Common Drug Review
□ Adaptation of Global model/Canadian model done by the manufacturer ⊠ Adaptation of Global model/Canadian model done by a private consultant contracted by the manufacturer □ Adaptation of Global model/Canadian model done by an academic consultant contracted by the manufacturer □ Other (please specify)
	Yes	No	Uncertain
Authors signed a letter indicating agreement with entire document	X
Authors had independent control over the methods and right to publish analysis		X

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK476292

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr. APPENDIX 2, ADDITIONAL INFORMATION.